Rebamipide reduces recurrence of experimental gastric ulcers: Role of free radicals and neutrophils

Digestive Diseases and Sciences

Volumn 50, Issue SUPPL. 1, 2005, Pages

  Sakurai, Kazushi ^a,c   Osaka, Toshihiro ^b   Yamasaki, Katsuya ^c  

^a Free Radical Research Institute   (Japan)

^b Otsuka Pharmaceutical Kagasuno K   (Japan)

^c OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Acetic acid induced ulcer; Free radicals; Neutrophils; Rebamipide; Ulcer recurrence

Indexed keywords

ACETIC ACID; ANTIOXIDANT; FREE RADICAL; GLUTATHIONE PEROXIDASE; MYELOPEROXIDASE; REBAMIPIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENT DISEASE; STOMACH ULCER; TREATMENT OUTCOME;

ACETIC ACID; ALANINE; ANIMALS; ANTI-ULCER AGENTS; FREE RADICALS; GASTRIC MUCOSA; GLUTATHIONE PEROXIDASE; INDICATORS AND REAGENTS; INFLAMMATION; LIPID PEROXIDATION; NEUTROPHIL INFILTRATION; PEROXIDASE; QUINOLONES; RATS; RECURRENCE; STOMACH ULCER; SUPEROXIDE DISMUTASE;

EID: 25644432760     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2812-5     Document Type: Article

References (41)

1. Marshall BJ, Goodwill CS, Warren JR, Murray R, Blincow ED, Blackbourn SJ, Phillips M, Waters TE, Sanderson CR: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2:1437-1442, 1988
2. Graham DY, Lew GM, Klein PD, Evans DG, Evans DJ Jr, Saeed ZA, Malaty HM: Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 116:705-708, 1992
3. Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, Kato M, Murakami K, Kato C, Shiotani A, Ohkusa T, Takagi A, Aoyama N, Haruma K, Okazaki K, Kusugami K, Suzuki M, Joh T, Azuma T, Yanaka A, Suzuki H, Hashimoto H, Kawai T, Sugiyama T: Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter 9:9-16, 2004
4. Graham DY, Agrawal NM, Campbell DR, Haber MM, Collis C, Lukasik NL, Huang B: NSAID-Associated Gastric Ulcer Prevention Study Group: Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs. lansoprazole. Arch Intern Med 162:169-175, 2002
5. Takagi K, Okabe S, Saziki R: A new method for the production of chronic gastric ulcer in rats and the effect of several drugs on its healing. Jpn J Pharmacol 19:418-426, 1969
6. Fukawa K, Kawano O, Misaki N, Uchida M, Irino O: Experimental studies on gastric ulcer (4). Sequential observation and evaluation of gastric ulcers by endoscope in the rat. Jpn J Pharmacol 33:175-179, 1983
7. Salim AS: Oxygen-derived free radicals and the prevention of duodenal ulcer relapse: a new approach. Am J Med Sci 300:1-6, 1990
8. Bhattacharjee M, Bhattacharjee S, Gupta A, Banerjee RK: Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and nonmediated gastric ulcer. Free Radic Biol Med 32:731-743, 2002
9. Satoh K, Kimura K, Yoshida Y, Kasano T, Kihira K, Taniguchi Y: A topographical relationship between Helicobacter pylori and gastritis: quantitative assessment of Helicobacter pylori in the gastric mucosa. Am J Gastroenterol 86:285-291, 1991
10. Dixon MF: Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 201(Suppl):7-10, 1994
11. Watanabe T, Arakawa T, Fukuda T, Higuchi K, Kobayashi K: Role of neutrophils in a rat model of gastric ulcer recurrence caused by interleukin-1β. Am J Pathol 150:971-979, 1997
12. Takahashi S, Keto Y, Fujita H, Muramatsu H, Nishino T, Okabe S: Pathological changes in the formation of Helicobacter pylori-induced gastric lesions in Mongolian gerbils. Dig Dis Sci 43(4):754-765, 1998
13. Vaananen PM, Meddings JB, Wallace JL: Role of oxygen-derived free radicals in indomethacin-induced gastric injury. Am J Physiol 261:G470-G475, 1991
14. Naito Y, Yoshikawa T, Ando T, Kishi A, Ueda S, Oyamada H, Kondo M: Changes in superoxide dismutase activity in the gastric mucosa of peptic ulcer patients. J Clin Gastroenterol 14:S131-S134, 1992
15. Hirokawa K, Kawasaki H: Changes in glutathione in gastric mucosa of gastric ulcer patients. Res Commun Mol Pathol Pharmacol 88(2):163-176, 1995
16. Oshima A, Asayama K, Sakai N, Kitajima M: The role of endogenous free radical scavengers on tissue recovery in the experimental ulcer model. J Clin Gastroenterol 12:S58-S64, 1990
17. Yamasaki K, Ishiyama H, Imaizumi T, Kanbe T, Yabuuchi Y: Effect of OPC-12759, a novel antiulcer agent, on chronic and acute experimental gastric ulcer, and gastric secretion in rats. Jpn J Pharmacol 49:441-448, 1989
18. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K: Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci 40:2469-2472, 1995
19. Tarnawski A, Arakawa T, Kobayashi K: Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig Dis Sci 43:90S-98S, 1998
20. Udagawa A, Shiota G, Ichiba M, Murawaki Y: Effect of rebamipide on acetic acid-induced gastric ulcer in rats: involvement of hepatocyte growth factor. Scand J Gastroenterol 38:141-146, 2003
21. Yoshikawa T, Naito Y, Tanigawa T, Kondo M: Free radical scavenging activity of the novel antiulcer agent rebamipide studied by electron spin resonance. Arzneimittelforschung 43:363-366, 1993
22. Naito Y, Yoshikawa T, Tanigawa T, Sakurai K, Yamasaki K, Uchida M, Kondo M: Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. Free Radic Biol Med 18:117-123, 1995
23. Sakurai K, Sasabe H, Koga T, Konishi T: Mechanism of hydroxyl radical scavenging by rebamipide: identification of monohydroxylated rebamipide as a major reaction product. Free Radic Res 38:487-194, 2004
24. Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyldithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 212:9-13, 1992
25. Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M: Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35:1375-1378, 1994
26. Nagano C, Azuma A, Ishiyama H, Sekiguchi K, Imagawa K, Kikuchi M: Rebamipide suppresses formyl-methionyl-leucylphenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils. J Pharmacol Exp Ther 297:388-394, 2001
27. Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Morita S: Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 142:23-29, 1987
28. Kleine A, Kluge S, Peskar BM: Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci 38:1441-1449, 1993
29. Sun WH, Tsuji S, Tsujii M, Gunawan ES, Kawai N, Kimura A, Kakiuchi Y, Yasumaru M, Iijima H, Okuda Y, Sasaki Y, Hori M, Kawano S: Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Exp Ther 295:447-452, 2000
30. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350, 1984
31. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358, 1979
32. Lowry OH, Rosebrough NJ, Farr AL, Randall RL: Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
33. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158-169, 1967
34. Oyanagui Y: Reevaluation of assay methods and establishment of kit for superoxide dismutase activity. Anal Biochem 142:290-296, 1984
35. Valle J, Seppala K, Sipponen P, Kosunen T: Disappearance of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand J Gastroenterol 26:1057-1065, 1991
36. Malfertheiner P, Bayerdorffer E, Diete U, Gil J, Lind T, Misiuna P, O'Morain C, Sipponen P, Spiller RC, Stasiewicz J, Treichel H, Ujszaszy L, Unge P, Zanten SJ, Zeijlon L: The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther 13:703-712, 1999
37. Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 96:29-36, 1989
38. Yoshida N, Yoshikawa T, Nakamura Y, Arai M, Matsuyama K, Iinuma S, Yagi N, Naito Y, Miyasaka M, Kondo M: Role of neutrophil-mediated inflammation in aspirin-induced gastric mucosal injury. Dig Dis Sci 40:2300-2304, 1995
39. Sakurai K, Yamasaki K: Protective effect of rebamipide against hydrogen peroxide-induced hemorrhagic mucosal lesions in rat stomach. Jpn J Pharmacol 64:229-234, 1994
40. Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 43:174S-180S, 1998
41. Watanabe T, Higuchi K, Tominaga K, Fujiwara Y, Arakawa T: Acid regulates inflammatory response in a rat model of induction of gastric ulcer recurrence by interleukin 1β. Gut 48:774-781, 2001